Skip to content

Scilex Holding Company SCLX Fair Value Of Treasury Warrants Expensed

Fair Value Of Treasury Warrants Expensed at other companies

Bowhead Specialty Holdings logo
Bowhead Specialty HoldingsBOW
$775K0.0%
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
-$5.94M+56.8%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
-$21.45M-4,364%
Laser Photonics Corporation logo
Laser Photonics CorporationLASE
$163.2K
The Beachbody Company logo
The Beachbody CompanyBODI
$191K-72.3%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$200K

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept sclx:FairValueOfTreasuryWarrantsExpensed.

The official record: Scilex Holding Company’s 10-K, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's fair value of treasury warrants expensed.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's fair value of treasury warrants expensed?
Scilex Holding Company (SCLX) reported fair value of treasury warrants expensed of $772.75K in Q4 2025.
What does fair value of treasury warrants expensed mean?
Reflects the non-cash expense recognized from the fair value measurement of treasury warrants. This metric highlights the impact of equity-linked financial instruments on the company's reported earnings.